UK experimental use exemptions: Part 4—the SPC manufacturing and stockpiling waiver

In the final article of a four-part series, Sophie Topham of Marks & Clerk discusses the supplementary protection certificate manufacturing waiver

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Europe

Final call: Who are the world’s best in-house counsel?

16 January 2026 A first-of-its-kind project by sister title WIPR aims to highlight the world’s leading in-house intellectual property counsel—and it needs your help.

Europe

Italian medtech startup beats larger US rival in UPC dispute

15 January 2026 Case between AorticLab and Emboline has implications for UPC playbook in terms of requesting security for costs, and conditional counterclaims.

Europe

Bayer secures key Denmark ruling as Xarelto faces expiry pressure

13 January 2026 As the drug moves deeper into its post-exclusivity phase, a Nordic decision highlights the value of secondary patents, presumption of validity, and interim relief when a drug's core patents expire.

More features

Winston & Strawn and Taylor Wessing UK seal ‘powerhouse’ merger

Firm adds seven-lawyer team in second major merger

Simpson Thacher adds ‘exemplary’ litigator with emerging tech expertise

AI is transforming top 100 innovators, shows index

Rooted in rights: Lessons from plant patent infringement and invalidity cases

$5.4bn medtech leader fails to bury a rival's patent

Final call: Who are the world’s best in-house counsel?

ITC to probe Oura Ring after Samsung retaliates, seeking import ban

UK experimental use exemptions: Part 4—the SPC manufacturing and stockpiling waiver

More on this story

Editor's picks

Editor's picks

More features